CompletedNCT00357006
A Definitive Estrogen Patch Study (ADEPT)
Medication studyAges 18–50AustraliaSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- MelbourneSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJuly 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 180
- Sponsor
- The Alfred
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Australia
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT00357006
- Official title
Show the full official title
Multisite Double-Blind Randomized Controlled Study of Estradiol Plus Antipsychotic Versus Placebo Plus Antipsychotic in the Treatment of Psychotic Symptoms in Women With Schizophrenia
Get this study by email
Recruitment & locations
CompletedMelbourne
Questions about this study
Who is behind this study?
The study sponsor is The Alfred.
Did this study involve medication?
Yes. The study involved medication, including Estradiol.
Who was this study for?
Listed age limits: 18 years to 50 years.
Want to explore more studies?
Explore studiesRelated studies
A placebo and comparator controlled phase 1, safety and tolerability study of 3 ascending doses of INP105 (intranasal OLZ by I231 POD® device).
Anti-Estrogens - A Potential Treatment for Bipolarity in Women?